The role of Nrf2-mediated pathway in cardiac remodeling and heart failure

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Zhou, Shanshan ^a   Sun, Wanqing ^a   Zhang, Zhiguo ^a   Zheng, Yang ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CELL DEATH; CHEMICAL COMPOUNDS; GENE EXPRESSION; OXIDATIVE STRESS; STRESSES;

ANTIOXIDANT DEFENSE; CARDIAC REMODELING; DETOXIFYING ENZYMES; INDUCIBLE EXPRESSION; MECHANICAL STRESS; PATHOPHYSIOLOGICAL; REACTIVE OXYGEN SPECIES; RELATED FACTORS;

HEART;

ANTINEOPLASTIC AGENT; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2;

ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; CAUSE OF DEATH; CELL PROTECTION; DETOXIFICATION; DIABETES MELLITUS; DISEASE COURSE; DRUG INDUCED DISEASE; GENE ACTIVATION; GENE EXPRESSION; GENE TARGETING; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART STRESS; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPLICATION; GENETICS; ISCHEMIA; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; RNA INTERFERENCE;

ANIMALS; DIABETES COMPLICATIONS; HEART FAILURE; HUMANS; HYPERTENSION; ISCHEMIA; MYOCARDIAL INFARCTION; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84904667280     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/260429     Document Type: Review

References (159)

1. Gutierrez J., Ballinger S. W., Darley-Usmar V. M., Landar A., Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circulation Research 2006 99 9 924 932 10.1161/01.RES.0000248212.86638.e9 2-s2.0-33750475625 (Pubitemid 44657795)
2. Guzik T. J., Harrison D. G., Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discovery Today 2006 11 11-12 524 533 10.1016/j.drudis.2006.04.003 2-s2.0-33646525680
3. Jialal I., Devaraj S., Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 2003 107 7 926 928 10.1161/01.CIR.0000048966.26216.4C 2-s2.0-0037465515 (Pubitemid 36258710)
4. Madamanchi N. R., Vendrov A., Runge M. S., Oxidative stress and vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 1 29 38 10.1161/01.ATV.0000150649.39934.13 2-s2.0-11144225245 (Pubitemid 40054251)
5. Murdoch C. E., Zhang M., Cave A. C., Shah A. M., NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovascular Research 2006 71 2 208 215 10.1016/j.cardiores.2006.03.016 2-s2.0-33745202365
6. Takimoto E., Kass D. A., Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 2007 49 2 241 248 10.1161/01.HYP.0000254415.31362. a7 2-s2.0-33846418746 (Pubitemid 46142995)
7. Li J., Ichikawa T., Villacorta L., Janicki J. S., Brower G. L., Yamamoto M., Cui T., Nrf2 protects against maladaptive cardiac responses to hemodynamic stress. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 11 1843 1850 10.1161/ATVBAHA.109.189480 2-s2.0-70350115341
8. Santos C. X. C., Anilkumar N., Zhang M., Brewer A. C., Shah A. M., Redox signaling in cardiac myocytes. Free Radical Biology and Medicine 2011 50 7 777 793 10.1016/j.freeradbiomed.2011.01.003 2-s2.0-79952041217
9. Thomas D. D., Ridnour L. A., Isenberg J. S., Flores-Santana W., Switzer C. H., Donzelli S., Hussain P., Vecoli C., Paolocci N., Ambs S., Colton C. A., Harris C. C., Roberts D. D., Wink D. A., The chemical biology of nitric oxide: implications in cellular signaling. Free Radical Biology & Medicine 2008 45 1 18 31 10.1016/j.freeradbiomed.2008.03.020 2-s2.0-45049084732
10. Dowling D. K., Simmons L. W., Reactive oxygen species as universal constraints in life-history evolution. Proceedings of the Royal Society B: Biological Sciences 2009 276 1663 1737 1745 10.1098/rspb.2008.1791 2-s2.0-66249107439
11. Scherz-Shouval R., Elazar Z., Regulation of autophagy by ROS: physiology and pathology. Trends in Biochemical Sciences 2011 36 1 30 38 10.1016/j.tibs.2010.07.007 2-s2.0-78650890352
12. Afanas'ev I., ROS and RNS signaling in heart disorders: could antioxidant treatment be successful? Oxidative Medicine and Cellular Longevity 2011 2011 13 293769 10.1155/2011/293769 2-s2.0-81555220895
13. Circu M. L., Aw T. Y., Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Biology and Medicine 2010 48 6 749 762 10.1016/j.freeradbiomed.2009.12.022 2-s2.0-76049083966
14. Bolli R., Zhu W. X., Hartley C. J., Michael L. H., Repine J. E., Hess M. L., Kukreja R. C., Roberts R., Attenuation of dysfunction in the postischemic "stunned" myocardium by dimethylthiourea. Circulation 1987 76 2 458 468 10.1161/01.CIR.76.2.458 2-s2.0-0023278986 (Pubitemid 17124750)
15. Beresewicz A., Horackova M., Alterations in electrical and contractile behavior of isolated cardiomyocytes by hydrogen peroxide: Possible ionic mechanisms. Journal of Molecular and Cellular Cardiology 1991 23 8 899 918 10.1016/0022-2828(91)90133-7 2-s2.0-0025822581
16. i-dependent coupling to phosphatidylinositol 3'-kinase. Circulation Research 2000 87 12 1172 1179 10.1161/01.RES.87.12.1172 2-s2.0-0034623819
17. Hybertson B. M., Gao B., Bose S. K., McCord J. M., Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Molecular Aspects of Medicine 2011 32 4-6 234 246 10.1016/j.mam.2011.10.006 2-s2.0-81855204961
18. Andrukhova O., Salama M., Rosenhek R., Gmeiner M., Perkmann T., Steindl J., Aharinejad S., Serum glutathione S-transferase P1 1 in prediction of cardiac function. Journal of Cardiac Failure 2012 18 3 253 261 10.1016/j.cardfail.2011. 11.003 2-s2.0-84857910173
19. Wu W., Qiu Q., Wang H., Whitman S. A., Fang D., Lian F., Zhang D. D., Nrf2 is crucial to graft survival in a rodent model of heart transplantation. Oxidative Medicine and Cellular Longevity 2013 2013 9 919313 10.1155/2013/919313 2-s2.0-84875487157
20. Zhu H., Itoh K., Yamamoto M., Zweier J. L., Li Y., Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury. FEBS Letters 2005 579 14 3029 3036 10.1016/j.febslet.2005.04.058 2-s2.0-20444381360 (Pubitemid 40797830)
21. Zhu H., Jia Z., Misra B. R., Zhang L., Cao Z., Yamamoto M., Trush M. A., Misra H. P., Li Y., Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress. Cardiovascular Toxicology 2008 8 2 71 85 10.1007/s12012-008-9016-0 2-s2.0-51449117002
22. Peake B. F., Nicholson C. K., Lambert J. P., Hood R. L., Amin H., Amin S., Calvert J. W., Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner. American Journal of Physiology: Heart and Circulatory Physiology 2013 304 9 H1215 H1224 10.1152/ajpheart.00796.2012 2-s2.0-84878618892
23. Zhang X., Xiao Z., Yao J., Zhao G., Fa X., Niu J., Participation of protein kinase C in the activation of Nrf2 signaling by ischemic preconditioning in the isolated rabbit heart. Molecular and Cellular Biochemistry 2013 372 1-2 169 179 10.1007/s11010-012-1458-9 2-s2.0-84870396636
24. Wiesel P., Patel A. P., Carvajal I. M., Wang Z. Y., Pellacani A., Maemura K., DiFonzo N., Rennke H. G., Layne M. D., Yet S., Lee M., Perrella M. A., Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circulation Research 2001 88 10 1088 1094 10.1161/hh1001.091521 2-s2.0-0035947746 (Pubitemid 34137123)
25. Hu C. M., Chen Y. H., Chiang M. T., Chau L. Y., Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. Circulation 2004 110 3 309 316 10.1161/01.CIR.0000135475.35758.23 2-s2.0-3242661655 (Pubitemid 38955500)
26. Lu Z., Xu X., Hu X., Zhu G., Zhang P., Van Deel E. D., French J. P., Fassett J. T., Oury T. D., Bache R. J., Chen Y., Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction. Hypertension 2008 51 1 19 25 10.1161/ HYPERTENSIONAHA.107.098186 2-s2.0-37349041037 (Pubitemid 350307094)
27. Matsushima S., Kinugawa S., Ide T., Matsusaka H., Inoue N., Ohta Y., Yokota T., Sunagawa K., Tsutsui H., Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart. American Journal of Physiology-Heart and Circulatory Physiology 2006 291 5 H2237 H2245 10.1152/ajpheart.00427.2006 2-s2.0-33751274535 (Pubitemid 44794216)
28. Hafstad A. D., Nabeebaccus A. A., Shah A. M., Novel aspects of ROS signalling in heart failure. Basic Research in Cardiology 2013 108 4, article 359 10.1007/s00395-013-0359-8 2-s2.0-84878396142
29. Maulik S. K., Kumar S., Oxidative stress and cardiac hypertrophy: a review. Toxicology Mechanisms and Methods 2012 22 5 359 366 10.3109/15376516. 2012.666650 2-s2.0-84860845011
30. Nattel S., Electrophysiologic remodeling: are ion channels static players or dynamic movers? Journal of Cardiovascular Electrophysiology 1999 10 11 1553 1556 10.1111/j.1540-8167.1999.tb00214.x 2-s2.0-0032705895 (Pubitemid 29529655)
31. Yu C., Lin H., Yang H., Kong S., Zhang Q., Lee S. W., Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 2002 105 10 1195 1201 10.1161/hc1002.105185 2-s2.0-0037066023 (Pubitemid 34225820)
32. Cai L., Li W., Wang G., Guo L., Jiang Y., James Kang Y., Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome c-mediated caspase-3 activation pathway. Diabetes 2002 51 6 1938 1948 10.2337/diabetes.51.6.1938 2-s2.0-0036267006 (Pubitemid 34564309)
33. Chang G. L., Zhang D. Y., Yu H., Cardioprotective effects of exenatide against oxidative stress-induced injury. International Journal of Molecular Medicine 2013 32 5 1011 1020 10.3892/ijmm.2013.1475
34. Zhao W. Y., Zhao T. Q., Chen Y. J., Ahokas R. A., Sun Y., Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Molecular and Cellular Biochemistry 2008 317 1-2 43 50 10.1007/s11010-008-9803-8 2-s2.0-53149102406
35. Johar S., Cave A. C., Narayanapanicker A., Grieve D. J., Shah A. M., Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. The FASEB Journal 2006 20 9 1546 1548 10.1096/fj.05-4642fje 2-s2.0-33746508654 (Pubitemid 44943825)
36. Gupta S., Das B., Sen S., Cardiac hypertrophy: mechanisms and therapeutic opportunities. Antioxidants and Redox Signaling 2007 9 6 623 652 10.1089/ars.2007.1474 2-s2.0-34249035782 (Pubitemid 46799096)
37. Sabri A., Hughie H. H., Lucchesi P. A., Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxidants and Redox Signaling 2003 5 6 731 740 10.1089/152308603770380034 2-s2.0-0345258510 (Pubitemid 37462056)
38. Huynh K., Bernardo B. C., McMullen. J. R., Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacology & Therapeutics 2014 142 3 375 415 10.1016/j.pharmthera.2014.01.003
39. van Empel V. P. M., Bertrand A. T. A., Hofstra L., Crijns H. J., Doevendans P. A., de Windt L. J., Myocyte apoptosis in heart failure. Cardiovascular Research 2005 67 1 21 29 10.1016/j.cardiores.2005.04.012 2-s2.0-20444431196 (Pubitemid 40798289)
40. Kannan K., Jain S. K., Oxidative stress and apoptosis. Pathophysiology 2000 7 3 153 163 10.1016/S0928-4680(00)00053-5 2-s2.0-0033805442
41. Kobayashi M., Yamamoto M., Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Advances in Enzyme Regulation 2006 46 1 113 140 10.1016/j.advenzreg.2006.01.007 2-s2.0-33748052967 (Pubitemid 44301353)
42. Li N., Nel A. E., Role of the Nrf2-mediated signaling pathway as a negative regulator of inflammation: Implications for the impact of particulate pollutants on asthma. Antioxidants and Redox Signaling 2006 8 1-2 88 98 10.1089/ars.2006.8.88 2-s2.0-33644652410 (Pubitemid 43324534)
43. Kensler T. W., Wakabayashi N., Biswal S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual Review of Pharmacology and Toxicology 2007 47 89 116 10.1146/annurev.pharmtox.46.120604. 141046 2-s2.0-33847050801
44. Kobayashi A., Ito E., Toki T., Kogame K., Takahashi S., Igarashi K., Hayashi N., Yamamoto M., Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3. The Journal of Biological Chemistry 1999 274 10 6443 6452 10.1074/jbc.274.10.6443 2-s2.0-0033525730 (Pubitemid 29111059)
45. Johnsen Ø., Murphy P., Prydz H., Kolstø A., Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: binding-site selection and regulation of transcription. Nucleic Acids Research 1998 26 2 512 520 10.1093/nar/26.2.512 2-s2.0-0032518185 (Pubitemid 28291577)
46. Marini M. G., Chan K., Casula L., Kan Y. W., Cao A., Moi P., hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2. The Journal of Biological Chemistry 1997 272 26 16490 16497 10.1074/jbc.272.26.16490 2-s2.0-0030974478 (Pubitemid 27276476)
47. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J. D., Yamamoto M., Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes and Development 1999 13 1 76 86 10.1101/gad.13.1.76 2-s2.0-0032953192 (Pubitemid 29045117)
48. Kobayashi A., Kang M., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M., Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Molecular and Cellular Biology 2004 24 16 7130 7139 10.1128/MCB.24.16.7130-7139.2004 2-s2.0-3543008924 (Pubitemid 39014439)
49. Yamamoto T., Suzuki T., Kobayashi A., Wakabayashi J., Maher J., Motohashi H., Yamamoto M., Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Molecular and Cellular Biology 2008 28 8 2758 2770 10.1128/MCB.01704-07 2-s2.0-42149196050 (Pubitemid 351542373)
50. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochemical and Biophysical Research Communications 1997 236 2 313 322 10.1006/bbrc.1997.6943 2-s2.0-0031577292 (Pubitemid 27373291)
51. Howden R., Nrf2 and cardiovascular defense. Oxidative Medicine and Cellular Longevity 2013 2013 10 104308 10.1155/2013/104308 2-s2.0-84877268399
52. Otterbein L. E., Choi A. M. K., Heme oxygenase: colors of defense against cellular stress. American Journal of Physiology: Lung Cellular and Molecular Physiology 2000 279 6 L1029 L1037 2-s2.0-0034529932 (Pubitemid 32009488)
53. Abraham N. G., Kappas A., Heme oxygenase and the cardiovascular-renal system. Free Radical Biology and Medicine 2005 39 1 1 25 10.1016/j. freeradbiomed.2005.03.010 2-s2.0-19544370917 (Pubitemid 40733115)
54. van Deel E. D., Lu Z., Xu X., Zhu G., Hu X., Oury T. D., Bache R. J., Duncker D. J., Chen Y., Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarction. Free Radical Biology and Medicine 2008 44 7 1305 1313 10.1016/j.freeradbiomed.2007. 12.007 2-s2.0-41049108634
55. Forman H. J., Zhang H., Rinna A., Glutathione: overview of its protective roles, measurement, and biosynthesis. Molecular Aspects of Medicine 2009 30 1-2 1 12 10.1016/j.mam.2008.08.006 2-s2.0-65049087190
56. Shiomi T., Tsutsui H., Matsusaka H., Murakami K., Hayashidani S., Ikeuchi M., Wen J., Kubota T., Utsumi H., Takeshita A., Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2004 109 4 544 549 10.1161/01.CIR.0000109701. 77059.E9 2-s2.0-10744225549 (Pubitemid 38168520)
57. Cai H., Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovascular Research 2005 68 1 26 36 10.1016/j.cardiores.2005.06.021 2-s2.0-24344499139 (Pubitemid 41253553)
58. Kohler J. J., Cucoranu I., Fields E., Green E., He S., Hoying A., Russ R., Abuin A., Johnson D., Hosseini S. H., Raper C. M., Lewis W., Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy. Laboratory Investigation 2009 89 7 782 790 10.1038/labinvest.2009.39 2-s2.0-67649861056
59. Savoia C., Burger D., Nishigaki N., Montezano A., Touyz R. M., Angiotensin II and the vascular phenotype in hypertension. Expert Reviews in Molecular Medicine 2011 13, article e11 10.1017/S1462399411001815 2-s2.0-79956160172
60. Sugamura K., Keaney J. F. Jr., Reactive oxygen species in cardiovascular disease. Free Radical Biology and Medicine 2011 51 5 978 992 10.1016/j.freeradbiomed.2011.05.004 2-s2.0-80051666038
61. Puddu P., Puddu G. M., Cravero E., Rosati M., Muscari A., The molecular sources of reactive oxygen species in hypertension. Blood Pressure 2008 17 2 70 77 10.1080/08037050802029954 2-s2.0-45949086327 (Pubitemid 351891172)
62. Tardiff J. C., Hewett T. E., Factor S. M., Vikstrom K. L., Robbins J., Leinwand L. A., Expression of the β (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. The American Journal of Physiology-Heart and Circulatory Physiology 2000 278 2 H412 H419 2-s2.0-0034095174 (Pubitemid 30131239)
63. Wakui H., Dejima T., Tamura K., Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension. Cardiovascular Research 2013 100 3 511 519 10.1093/cvr/cvt225
64. Wang H. X., Yang H., Han Q. Y., Nadph oxidases mediate a cellular "memory" of angiotensin ii stress in hypertensive cardiac hypertrophy. Free Radical Biology & Medicine 2013 65 897 907
65. Tsukamoto Y., Mano T., Sakata Y., A novel heart failure mice model of hypertensive heart disease by angiotensin ii infusion, nephrectomy, and salt loading. The American Journal of Physiology-Heart and Circulatory Physiology 2013 305 H1658 H1667
66. Xing Y., Niu T., Wang W., Li J., Li S., Janicki J. S., Ruiz S., Meyer C. J., Wang X. L., Tang D., Zhao Y., Cui T., Triterpenoid dihydro-cddo- trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2. PLoS ONE 2012 7 9 e44899 10.1371/journal.pone.0044899 2-s2.0-84866456998
67. Lin H., Li H. F., Chen H. H., Activating transcription factor 3 protects against pressure-overload heart failure via the autophagy molecule beclin-1 pathway. Molecular Pharmacology 2014 85 682 691
68. Ndisang J. F., Jadhav A., Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months. Journal of Cardiac Failure 2009 15 7 616 628 10.1016/j.cardfail. 2009.02.003 2-s2.0-68849093674
69. Mito S., Ozono R., Oshima T., Yano Y., Watari Y., Yamamoto Y., Brydun A., Igarashi K., Yoshizumi M., Myocardial protection against pressure overload in mice lacking bachl, a transcriptional repressor of heme oxygenase-1. Hypertension 2008 51 6 1570 1577 10.1161/HYPERTENSIONAHA.107.102566 2-s2.0-45849121729
70. Foo R. S. Y., Siow R. C. M., Brown M. J., Bennett M. R., Heme oxygenase-1 gene transfer inhibits angiotensin II-mediated rat cardiac myocyte apoptosis but not hypertrophy. Journal of Cellular Physiology 2006 209 1 1 7 10.1002/jcp.20723 2-s2.0-33748284288 (Pubitemid 44318662)
71. Chen C., Huo R., Tong Y., Sheng Y., Liu H., Gao X., Nakajima O., Yang B., Dong D., Systemic heme oxygenase-1 transgenic overexpression aggravates pressure overload-induced cardiac hypertrophy in mice. Cellular Physiology and Biochemistry 2011 28 1 25 32 10.1159/000331710 2-s2.0-80052020658
72. Hikoso S., Yamaguchi O., Nakano Y., Takeda T., Omiya S., Mizote I., Taneike M., Oka T., Tamai T., Oyabu J., Uno Y., Matsumura Y., Nishida K., Suzuki K., Kogo M., Hori M., Otsu K., The I B Kinase β /Nuclear factor b signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression. Circulation Research 2009 105 1 70 79 10.1161/CIRCRESAHA.108.193318 2-s2.0-67949112796
73. Lijnen P., Petrov V., van Pelt J., Fagard R., Inhibition of superoxide dismutase induces collagen production in cardiac fibroblasts. American Journal of Hypertension 2008 21 10 1129 1136 10.1038/ajh.2008.242 2-s2.0-52449132324
74. Richters L., Lange N., Renner R., Treiber N., Ghanem A., Tiemann K., Scharffetter-Kochanek K., Bloch W., Brixius K., Exercise-induced adaptations of cardiac redox homeostasis and remodeling in heterozygous SOD2-knockout mice. Journal of Applied Physiology 2011 111 5 1431 1440 10.1152/japplphysiol.01392. 2010 2-s2.0-81355163633
75. Takemura G., Nakagawa M., Kanamori H., Minatoguchi S., Fujiwara H., Benefits of reperfusion beyond infarct size limitation. Cardiovascular Research 2009 83 2 269 276 10.1093/cvr/cvp032 2-s2.0-67650242012
76. Eefting F., Rensing B., Wigman J., Pannekoek W. J., Liu W. M., Cramer M. J., Lips D. J., Doevendans P. A., Role of apoptosis in reperfusion injury. Cardiovascular Research 2004 61 3 414 426 10.1016/j.cardiores.2003.12.023 2-s2.0-1142297602 (Pubitemid 38210148)
77. Braunersreuther V., Jaquet V., Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches. Current Pharmaceutical Biotechnology 2012 13 1 97 114 10.2174/138920112798868782 2-s2.0-84855849542
78. Sun Y., Myocardial repair/remodelling following infarction: Roles of local factors. Cardiovascular Research 2009 81 3 482 490 10.1093/cvr/cvn333 2-s2.0-59449107442
79. Deng C., Sun Z., Tong G., Yi W., Ma L., Zhao B., Cheng L., Zhang J., Cao F., Yi D., Alpha-lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of pi3k/akt/nrf2 pathway. PLoS ONE 2013 8 3 e58371 10.1371/journal.pone.0058371 2-s2.0-84874678796
80. Ashrafian H., Czibik G., Bellahcene M., Aksentijević D., Smith A. C., Mitchell S. J., Dodd M. S., Kirwan J., Byrne J. J., Ludwig C., Isackson H., Yavari A., Støttrup N. B., Contractor H., Cahill T. J., Sahgal N., Ball D. R., Birkler R. I. D., Hargreaves I., Tennant D. A., Land J., Lygate C. A., Johannsen M., Kharbanda R. K., Neubauer S., Redwood C., De Cabo R., Ahmet I., Talan M., Günther U. L., Robinson A. J., Viant M. R., Pollard P. J., Tyler D. J., Watkins H., Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metabolism 2012 15 3 361 371 10.1016/j.cmet.2012.01. 017 2-s2.0-84863244462
81. 2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2. Hypertension 2014 63 1 80 87 10.1161/HYPERTENSIONAHA. 113.01639
82. Iliodromitis E. K., Lazou A., Kremastinos D. T., Ischemic preconditioning: protection against myocardial necrosis and apoptosis. Vascular Health and Risk Management 2007 3 5 629 637 2-s2.0-36148934452 (Pubitemid 350104118)
83. Gurusamy N., Malik G., Gorbunov N. V., Das D. K., Redox activation of Ref-1 potentiates cell survival following myocardial ischemia reperfusion injury. Free Radical Biology & Medicine 2007 43 3 397 407 10.1016/j.freeradbiomed.2007.04.025 2-s2.0-34250887598 (Pubitemid 46977631)
84. Grabellus F., Schmid C., Levkau B., Breukelmann D., Halloran P. F., August C., Takeda N., Takeda A., Wilhelm M., Deng M. C., Baba H. A., Reduction of hypoxia-inducible heme oxygenase-1 in the myocardium after left ventricular mechanical support. Journal of Pathology 2002 197 2 230 237 10.1002/path.1106 2-s2.0-0036262210 (Pubitemid 34567611)
85. Raju V. S., Imai N., Liang C. S., Chamber-specific regulation of heme oxygenase-1 (heat shock protein 32) in right-sided congestive heart failure. Journal of Molecular and Cellular Cardiology 1999 31 8 1581 1589 10.1006/jmcc.1999.0995 2-s2.0-0033178649 (Pubitemid 29361124)
86. Wang G., Hamid T., Keith R. J., Zhou G., Partridge C. R., Xiang X., Kingery J. R., Lewis R. K., Li Q., Rokosh D. G., Ford R., Spinale F. G., Riggs D. W., Srivastava S., Bhatnagar A., Bolli R., Prabhu S. D., Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 2010 121 17 1912 1925 10.1161/CIRCULATIONAHA.109.905471 2-s2.0-77951878150
87. Vulapalli S. R., Chen Z., Chua B. H. L., Wang T., Liang C., Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. American Journal of Physiology: Heart and Circulatory Physiology 2002 283 2 H688 H694 2-s2.0-0036070456 (Pubitemid 34790864)
88. Yoshida T., Maulik N., Ho Y. S., Alam J., Das D. K., H mox-1 constitutes an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the heme oxygenase-1 gene. Circulation 2001 103 12 1695 1701 10.1161/01.CIR.103.12.1695 2-s2.0-0035957249 (Pubitemid 32246619)
89. Yet S., Tian R., Layne M. D., Yuan Wang Z., Maemura K., Solovyeva M., Ith B., Melo L. G., Zhang L., Ingwall J. S., Dzau V. J., Lee M., Perrella M. A., Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circulation Research 2001 89 2 168 173 10.1161/hh1401.093314 2-s2.0-0035920256 (Pubitemid 34135825)
90. Melo L. G., Agrawal R., Zhang L., Rezvani M., Mangi A. A., Ehsan A., Griese D. P., Dell'Acqua G., Mann M. J., Oyama J., Yet S., Layne M. D., Perrella M. A., Dzau V. J., Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002 105 5 602 607 10.1161/hc0502.103363 2-s2.0-0037022253 (Pubitemid 34123435)
91. Liu X., Simpson J. A., Brunt K. R., Ward C. A., Hall S. R. R., Kinobe R. T., Barrette V., Tse M. Y., Pang S. C., Pachori A. S., Dzau V. J., Ogunyankin K. O., Melo L. G., Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction. American Journal of Physiology: Heart and Circulatory Physiology 2007 293 1 H48 H59 10.1152/ajpheart.00741.2006 2-s2.0-34547137161 (Pubitemid 47105058)
92. Kuzuya T., Hoshida S., Yamashita N., Fuji H., Oe H., Hori M., Kamada T., Tada M., Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circulation Research 1993 72 6 1293 1299 10.1161/01.RES.72.6.1293 2-s2.0-0027222962 (Pubitemid 23147612)
93. Dana A., Baxter G. F., Yellon D. M., Both protein kinase c and protein tyrosine kinase mediate adenosine induced delayed cardioprotection in rabbits. Circulation 1997 96 6 1745 1749 10.1161/01.CIR.96.6.1745
94. Yoshida T., Watanabe M., Eagelman D. T., Engelman R. M., Schley J. A., Maulik N., Ho Y., Oberley T. D., Das D. K., Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. Journal of Molecular and Cellular Cardiology 1996 28 8 1759 1767 10.1006/jmcc.1996.0165 2-s2.0-0030218917 (Pubitemid 26300575)
95. Yoshida T., Maulik N., Engelman R. M., Ho Y., Magnenat J., Rousou J. A., Flack J. E. III, Deaton D., Das D. K., Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation 1997 96 9 II216 II220 2-s2.0-0342871961 (Pubitemid 27500034)
96. Dabkowski E. R., Williamson C. L., Hollander J. M., Mitochondria-specific transgenic overexpression of phospholipid hydroperoxide glutathione peroxidase (GPx4) attenuates ischemia/reperfusion-associated cardiac dysfunction. Free Radical Biology and Medicine 2008 45 6 855 865 10.1016/j.freeradbiomed.2008.06. 021 2-s2.0-54949154110
97. Cai L., Kang Y. J., Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovascular Toxicology 2001 1 3 181 193 10.1385/CT:1:3:181 2-s2.0-0035749812 (Pubitemid 37013746)
98. Ramprasath T., Selvam G. S., Potential impact of genetic variants in nrf2 regulated antioxidant genes and risk prediction of diabetes and associated cardiac complications. Current Medicinal Chemistry 2013 20 4680 4693 10.2174/09298673113209990154
99. Nishikawa T., Edelstein D., Du X. L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M. A., Beebe D., Oates P. J., Hammes H., Glardino I., Brownlee M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000 404 6779 787 790 10.1038/35008121 2-s2.0-0034643340 (Pubitemid 30212409)
100. Inoguchi T., Li P., Umeda F., Yu H. Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Utsumi H., Nawata H., High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000 49 11 1939 1945 10.2337/diabetes.49.11.1939 2-s2.0-0033765672
101. Cai L., Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications. Current Medicinal Chemistry 2007 14 20 2193 2203 10.2174/092986707781389646 2-s2.0-35348893135 (Pubitemid 47578157)
102. Piao C. S., Gao S., Lee G., Kim D. S., Park B., Chae S. W., Chae H., Kim S. H., Sulforaphane protects ischemic injury of hearts through antioxidant pathway and mitochondrial KATP channels. Pharmacological Research 2010 61 4 342 348 10.1016/j.phrs.2009.11.009 2-s2.0-77649341955
103. Bai Y., Cui W., Xin Y., Miao X., Barati M. T., Zhang C., Chen Q., Tan Y., Cui T., Zheng Y., Cai L., Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation. Journal of Molecular and Cellular Cardiology 2013 57 1 82 95 10.1016/j.yjmcc.2013.01.008 2-s2.0-84873737258
104. Chen B., Ma Y., Meng R., Xiong Z., Zhang C., Chen G., Zhang A., Dong Y., MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals. Acta Biochimica et Biophysica Sinica (Shanghai) 2010 42 4 253 258 10.1093/abbs/gmq012 2-s2.0-77950553729
105. Ma Y., Chen Y., Yang Y., Chen B., Liu D., Xiong Z., Zhang C., Dong Y., Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression. Biochemical Pharmacology 2013 85 2 223 233 10.1016/j.bcp.2012.10.025 2-s2.0-84872010741
106. Wang Y., Sun W., Du B., Miao X., Bai Y., Xin Y., Tan Y., Cui W., Liu B., Cui T., Epstein P. N., Fu Y., Cai L., Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF- B. American Journal of Physiology: Heart and Circulatory Physiology 2013 304 4 H567 H578 10.1152/ajpheart.00650.2012 2-s2.0-84874051303
107. Gurusamy N., Ray D., Lekli I., Das D. K., Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium. Journal of Cellular and Molecular Medicine 2010 14 9 2235 2239 10.1111/j.1582-4934. 2010.01140.x 2-s2.0-78649346690
108. Li X., Li C., Xiang Z., Hu J., Lu J., Tian R., Jia W., Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways. Cardiovascular Drugs and Therapy 2012 26 6 457 465 10.1007/s10557-012-6415-z 2-s2.0-84876406102
109. Calvert J. W., Jha S., Gundewar S., Elrod J. W., Ramachandran A., Pattillo C. B., Kevil C. G., Lefer D. J., Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circulation Research 2009 105 4 365 374 10.1161/CIRCRESAHA.109.199919 2-s2.0-70349233030
110. Zhang Y., Sano M., Shinmura K., Tamaki K., Katsumata Y., Matsuhashi T., Morizane S., Ito H., Hishiki T., Endo J., Zhou H., Yuasa S., Kaneda R., Suematsu M., Fukuda K., 4-Hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway. Journal of Molecular and Cellular Cardiology 2010 49 4 576 586 10.1016/j.yjmcc.2010.05.011 2-s2.0-77956101963
111. Chen T. M., Li J., Liu L., Fan L., Li X., Wang Y., Abraham N. G., Cao J., Effects of heme oxygenase-1 upregulation on blood pressure and cardiac function in an animal model of hypertensive myocardial infarction. International Journal of Molecular Sciences 2013 14 2 2684 2706 10.3390/ijms14022684 2-s2.0-84875103276
112. Collino M., Pini A., Mugelli N., Mastroianni R., Bani D., Fantozzi R., Papucci L., Fazi M., Masini E., Beneficial effect of prolonged heme oxygenase 1 activation in a rat model of chronic heart failure. Disease Models and Mechanisms 2013 6 4 1012 1020 10.1242/dmm.011528 2-s2.0-84880020046
113. van Empel V. P. M., Bertrand A. T., van Oort R. J., van der Nagel R., Engelen M., van Rijen H. V., Doevendans P. A., Crijns H. J., Ackerman S. L., Sluiter W., De Windt L. J., EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. Journal of the American College of Cardiology 2006 48 4 824 832 10.1016/j.jacc.2006.02.075 2-s2.0-33746789436 (Pubitemid 44175721)
114. Xia Z., Guo Z., Nagareddy P. R., Yuen V., Yeung E., McNeill J. H., Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats. European Journal of Pharmacology 2006 544 1-3 118 125 10.1016/j.ejphar.2006.06.033 2-s2.0-33746647309 (Pubitemid 44148577)
115. He X., Kan H., Cai L., Ma Q., Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. Journal of Molecular and Cellular Cardiology 2009 46 1 47 58 10.1016/j.yjmcc.2008.10.007 2-s2.0-57249104720
116. Tan Y., Ichikawa T., Li J., Si Q., Yang H., Chen X., Goldblatt C. S., Meyer C. J., Li X., Cai L., Cui T., Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 2011 60 2 625 633 10.2337/db10-1164 2-s2.0-79551575483
117. Li B., Liu S., Miao L., Cai L., Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy. Experimental Diabetes Research 2012 2012 7 216512 10.1155/2012/216512 2-s2.0-84862282913
118. Chen Y., Lin S., Lin M., Tsai H., Kuo S., Chen J., Charng M., Wu T., Chen L., Ding P. Y., Pan W., Jou Y., Chau L., Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Human Genetics 2002 111 1 1 8 10.1007/s00439-002-0769-4 2-s2.0-0036664867 (Pubitemid 36075012)
119. Zhao Y., Zhang L., Qiao Y., Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy. PLoS ONE 2013 8 9 e75927 10.1371/journal. pone.0075927
120. Liu X., Wei J., Peng D. H., Layne M. D., Yet S., Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. Diabetes 2005 54 3 778 784 10.2337/diabetes.54.3.778 2-s2.0-14644400430 (Pubitemid 40322082)
121. Shen X., Zheng S., Metreveli N. S., Epstein P. N., Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 2006 55 3 798 805 10.1562/2005-10-20-RN-723 2-s2.0-33644766038
122. Iwata K., Nishinaka T., Matsuno K., Yabe-Nishimura C., Increased gene expression of glutathione peroxidase-3 in diabetic mouse heart. Biological and Pharmaceutical Bulletin 2006 29 5 1042 1045 10.1248/bpb.29.1042 2-s2.0-33646450259
123. Cardinale D., Bacchiani G., Beggiato M., Colombo A., Cipolla C. M., Strategies to prevent and treat cardiovascular risk in cancer patients. Seminars in Oncology 2013 40 2 186 198 10.1053/j.seminoncol.2013.01.008 2-s2.0-84875730564
124. Ichihara S., Yamada Y., Kawai Y., Osawa T., Furuhashi K., Duan Z., Ichihara G., Roles of oxidative stress and Akt signaling in doxorubicin cardiotoxicity. Biochemical and Biophysical Research Communications 2007 359 1 27 33 10.1016/j.bbrc.2007.05.027 2-s2.0-34249649617 (Pubitemid 46836667)
125. Sumi D., Sasaki T., Miyataka H., Himeno S., Rat H9c2 cardiac myocytes are sensitive to arsenite due to a modest activation of transcription factor Nrf2. Archives of Toxicology 2011 85 12 1509 1516 10.1007/s00204-011-0700-7 2-s2.0-82355182875
126. Shenkenberg T. D., VonHoff D. D., Mitoxantrone: a new anticancer drug with significant clinical activity. Annals of Internal Medicine 1986 105 1 67 81 10.7326/0003-4819-105-1-67 2-s2.0-0022637854 (Pubitemid 16097929)
127. Vávrová A., Popelová O., Štěrba M., Jirkovský E., Hašková P., Mertlíková- Kaiserová H., Geršl V., Šimůnek T., In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity. Archives of Toxicology 2011 85 5 525 535 10.1007/s00204-010-0615-8 2-s2.0-79956353957
128. Nordgren K. K., Wallace K. B., Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts. Toxicology and Applied Pharmacology 2013 274 107 116
129. Menzel D. B., Rasmussen R. E., Lee E., Meacher D. M., Said B., Hamadeh H., Vargas M., Greene H., Roth R. N., Human lymphocyte home oxygenase 1 as a response biomarker to inorganic arsenic. Biochemical and Biophysical Research Communications 1998 250 3 653 656 10.1006/bbrc.1998.9363 2-s2.0-0032578361 (Pubitemid 28484783)
130. Kumagai Y., Sumi D., Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annual Review of Pharmacology and Toxicology 2007 47 243 262 10.1146/annurev.pharmtox.47. 120505.105144 2-s2.0-33847075357
131. Jirkovský E., Popelová O., Křiváková- Staňková P., Vávrová A., Hroch M., Hašková P., Brčáková-Doleželová E., Mičuda S., Adamcová M., Šimůnek T., Červinková Z., Geršl V., Štěrba M., Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways. Journal of Pharmacology and Experimental Therapeutics 2012 343 2 468 478 10.1124/jpet.112.1983583 2-s2.0-84867608210
132. Balogun E., Hoque M., Gong P., Killeen E., Green C. J., Foresti R., Alam J., Motterlini R., Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochemical Journal 2003 371 3 887 895 10.1042/BJ20021619 2-s2.0-0037569694 (Pubitemid 36578887)
133. Venkatesan N., Curcumin attenuation of acute adriamycin myocardial toxicity in rats. British Journal of Pharmacology 1998 124 3 425 427 10.1038/sj.bjp.0701877 2-s2.0-0031801988 (Pubitemid 28254494)
134. Gorbunov N., Petrovski G., Gurusamy N., Ray D., Kim D. H., Das D. K., Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells. Journal of Cellular and Molecular Medicine 2012 16 1 174 184 10.1111/j.1582-4934.2011.01281.x 2-s2.0-84855173613
135. Jeong W. S., Jun M., Kong A. N. T., Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxidants and Redox Signaling 2006 8 1-2 99 106 10.1089/ars.2006.8.99 2-s2.0-33644649421 (Pubitemid 43324535)
136. Kensler T. W., Curphey T. J., Maxiutenko Y., Roebuck B. D., Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins. Drug Metabolism and Drug Interactions 2000 17 1-4 3 22 2-s2.0-0034522060 (Pubitemid 32047530)
137. Seymour E. M., Bennink M. R., Bolling S. F., Diet-relevant phytochemical intake affects the cardiac AhR and Nrf2 transcriptome and reduces heart failure in hypertensive rats. Journal of Nutritional Biochemistry 2013 24 9 1580 1586 10.1016/j.jnutbio.2013.01.008 2-s2.0-84881555348
138. Brewer A. C., Murray T. V. A., Arno M., Zhang M., Anilkumar N. P., Mann G. E., Shah A. M., Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. Free Radical Biology and Medicine 2011 51 1 205 215 10.1016/j.freeradbiomed.2011.04.022 2-s2.0-79957954491
139. Kuroda J., Ago T., Matsushima S., Zhai P., Schneider M. D., Sadoshima J., NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proceedings of the National Academy of Sciences of the United States of America 2010 107 35 15565 15570 10.1073/pnas.1002178107 2-s2.0-77957272433
140. Dreger H., Westphal K., Weller A., Baumann G., Stangl V., Meiners S., Stangl K., Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovascular Research 2009 83 2 354 361 10.1093/cvr/cvp107 2-s2.0-67650229881
141. Sahni S. K., Rydkina E., Sahni A., The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenase-2 expression in human vascular endothelial cells. Thrombosis Research 2008 122 6 820 825 10.1016/j.thromres.2008.01.011 2-s2.0-52049100130
142. Cui W., Bai Y., Luo P., Miao L., Cai L., Preventive and therapeutic effects of mg132 by activating nrf2-are signaling pathway on oxidative stress-induced cardiovascular and renal injury. Oxidative Medicine and Cellular Longevity 2013 2013 10 306073 10.1155/2013/306073 2-s2.0-84875527422
143. Yu J., Zhao Y., Li B., Sun L., Huo H., 17 β -Estradiol regulates the expression of antioxidant enzymes in myocardial cells by increasing Nrf2 translocation. Journal of Biochemical and Molecular Toxicology 2012 26 7 264 269 10.1002/jbt.21417 2-s2.0-84864008286
144. Cai C., Teng L., Vu D., He J., Guo Y., Li Q., Tang X., Rokosh G., Bhatnagar A., Bolli R., The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. Journal of Biological Chemistry 2012 287 40 33720 33732 10.1074/jbc.M112.385542 2-s2.0-84866890498
145. Worou M. E., Belmokhtar K., Bonnet P., Vourch P., MacHet M. C., Khamis G., Eder V., Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling. Cardiovascular Research 2011 91 2 320 329 10.1093/cvr/cvr072 2-s2.0-79959925200
146. Di Filippo C., Marfella R., Cuzzocrea S., Piegari E., Petronella P., Giugliano D., Rossi F., D'Amico M., Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial H0-1 during ischemia/reperfusion. Diabetes 2005 54 3 803 810 10.2337/diabetes.54.3.803 2-s2.0-14644431753 (Pubitemid 40322085)
147. Wang G. G., Li W., Lu X. H., Zhao X., Xu L., Taurine attenuates oxidative stress and alleviates cardiac failure in type 1 diabetic rats. Croatian Medical Journal 2013 54 2 171 179 10.3325/cmj.2013.54.171 2-s2.0-84878197549
148. Gnecchi M., He H., Noiseux N., Liang O. D., Zhang L., Morello F., Mu H., Melo L. G., Pratt R. E., Ingwall J. S., Dzau V. J., Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. The FASEB Journal 2006 20 6 661 669 10.1096/fj.05-5211com 2-s2.0-33646252939 (Pubitemid 44933310)
149. Zeng B., Ren X., Lin G., Zhu C., Chen H., Yin J., Jiang H., Yang B., Ding D., Paracrine action of HO-1-modified mesenchymal stem cells mediates cardiac protection and functional improvement. Cell Biology International 2008 32 10 1256 1264 10.1016/j.cellbi.2008.07.010 2-s2.0-52949094613
150. Müller-Ehmsen J., Krausgrill B., Burst V., Schenk K., Neisen U. C., Fries J. W. U., Fleischmann B. K., Hescheler J., Schwinger R. H. G., Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. Journal of Molecular and Cellular Cardiology 2006 41 5 876 884 10.1016/j.yjmcc.2006.07.023 2-s2.0-33750380756 (Pubitemid 44635568)
151. Tang Y. L., Zhang Y. C., Qian K., Shen L., Phillips M. I., Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. Journal of the American College of Cardiology 2005 46 7 1339 1350 10.1016/j.jacc.2005.05.079 2-s2.0-27744505661 (Pubitemid 41615559)
152. Shu T., Zeng B., Ren X., Li Y., HO-1 modified mesenchymal stem cells modulate MMPs/TIMPs system and adverse remodeling in infarcted myocardium. Tissue and Cell 2010 42 4 217 222 10.1016/j.tice.2010.04.004 2-s2.0-77955925294
153. Zeng B., Lin G., Ren X., Zhang Y., Chen H., Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium. Journal of Biomedical Science 2010 17 1, article 80 10.1186/1423-0127-17-80 2-s2.0-77957348619
154. Hatori N., Sjoquist P., Marklund S. L., Pehrsson S. K., Ryden L., Effects of recombinant human extracellular-superoxide dismutase type C on myocardial reperfusion injury in isolated cold-arrested rat hearts. Free Radical Biology and Medicine 1992 13 2 137 142 10.1016/0891-5849(92)90075-R 2-s2.0-0026704438
155. Sjoquist P. O., Carlsson L., Jonason G., Marklund S. L., Abrahamsson T., Cardioprotective effects of recombinant human extracellular-superoxide dismutase type C in rat isolated heart subjected to ischemia and reperfusion. Journal of Cardiovascular Pharmacology 1991 17 4 678 683 10.1097/00005344-199104000-00023 2-s2.0-0025852144
156. Sjoquist P.-O., Marklund S. L., Endothelium bound extracellular superoxide dismutase type C reduces damage in reperfused ischaemic rat hearts. Cardiovascular Research 1992 26 4 347 350 10.1093/cvr/26.4.347 2-s2.0-0026506581
157. Hatori N., Sjöquist P.-O., Marklund S. L., Ryden L., Effects of recombinant human extracellular-superoxide dismutase type C on myocardial infarct size in pigs. Free Radical Biology and Medicine 1992 13 3 221 230 10.1016/0891-5849(92)90018-C 2-s2.0-0026725575
158. Konkalmatt P. R., Beyers R. J., O'Connor D. M., Xu Y., Seaman M. E., French B. A., Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling. Circulation: Cardiovascular imaging 2013 6 3 478 486 10.1161/CIRCIMAGING.112.000320 2-s2.0-84880224247
159. Liu T. C. K., Ismail S., Brennan O., Hastings C., Duffy G. P., Encapsulation of cardiac stem cells in superoxide dismutase-loaded alginate prevents doxorubicin-mediated toxicity. Journal of Tissue Engineering and Regenerative Medicine 2013 7 4 302 311 10.1002/term.523 2-s2.0-84875809439